MNKD
Mannkind Corp
NASDAQ · Biotechnology
$5.78
+0.27 (+4.90%)
Open$5.59
Previous Close$5.51
Day High$5.86
Day Low$5.53
52W High$6.51
52W Low$3.38
Volume—
Avg Volume4.07M
Market Cap1.77B
P/E Ratio61.72
EPS$0.09
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+446.9% upside
Current
$5.78
$5.78
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 308.85M | 198.16M | 251.93M |
| Net Income | 29.85M | 17.24M | -42,108,140 |
| Profit Margin | 9.7% | 9.2% | -16.7% |
| EBITDA | 65.87M | 40.15M | -75,539,196 |
| Free Cash Flow | — | — | -20,831,578 |
| Rev Growth | +55.9% | +55.9% | +16.1% |
| Debt/Equity | 1.64 | 1.64 | 1.04 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |